CD19 Recombinant Rabbit mAb (Cy5 Conjugate) (S-164-41)

產(chǎn)品型號：S0B0169

更新時間：2025-10-10

廠商性質(zhì)：生產(chǎn)廠家

訪問量：142

服務熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

如何選擇合適的偶聯(lián)抗體用于實驗研究？

熒光偶聯(lián)抗體：如何在生物醫(yī)學研究中實現(xiàn)精準檢測？

視黃醇結合蛋白4（RBP4）抗體：發(fā)掘其在疾病風險中的診斷潛力

腫瘤靶點的“新寵”-Claudin18.2抗體現(xiàn)貨！

產(chǎn)品介紹

The CD19 antigen plays an important role in clinical oncology. In normal cells, it is the most ubiquitously expressed protein in the B lymphocyte lineage. CD19 expression is induced at the point of B lineage commitment during the differentiation of the hematopoietic stem cell, and its expression continues through preB and mature B cell differentiation until it is finally down-regulated during terminal differentiation into plasma cells. CD19 expression is maintained in B-lineage cells that have undergone neoplastic transformation, and therefore CD19 is useful in diagnosis of leukemias and lymphomas using monoclonal antibodies （mAbs） and flow cytometry [PMID: 8528044].

上一個：S0B0437Bevacizumab